 Home > Active Ingredient News > Digestive System Information > Nat Commun: Timely vaccination after birth will completely eliminate the impact of hepatitis B

Nat Commun: Timely vaccination after birth will completely eliminate the impact of hepatitis B

 Last Update: 2021-11-11
 Source: Internet
 Author: User

Tags

hinge health careers

1 year subscription

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Since the introduction of the hepatitis B virus (HBV) vaccine in the 1980s, HBV infection has continued to pose a major public health threat in the past 40 years, and its impact on low- and middle-income countries (LMICs) is particularly prominent

Infect

By 2016, the World Health Assembly approved a strategy for the World Health Organization (WHO), that is by 2030 to eliminate HBV this public health threat, it is a measure of the 5-year-old 2030 children of HBV surface antigen (HBsAg) suffering The disease rate was reduced to 0.

child

At present, in most countries, by expanding the coverage of infant HBV series vaccines, horizontal transmission has been greatly reduced , so vertical transmission is becoming more and more important

By expanding the coverage of infant HBV series vaccines, horizontal transmission has been greatly reduced.

The overall impact of timely expansion of the scale of HB-BD on the global burden of disease

In addition, maintaining this situation may lead to the elimination of hepatitis B in the Americas by 2030, but Africa will not eliminate it before 2059

Maintaining this situation may cause the Americas to eliminate hepatitis B before 2030, but Africa will not eliminate it before 2059.

Original source:

Margaret J.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Vonoprazan

CAS No.: 1260141-27-2

Pharmacy Grade

$3483/KG FOB

Magnesium oxide

CAS No.: 1309-48-4

Industrial Grade

$491-498/MT FOB

Famotidine (Gastrointestinal)

CAS No.: 76824-35-6

Pharmacy Grade

$1/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.